NCT02367131View on ClinicalTrials.gov

Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

419

Participants

Timeline

Start Date

February 24, 2015

Primary Completion Date

September 27, 2016

Study Completion Date

September 27, 2016

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

JARDIANCE®

JARDIANCE®

Trial Locations (1)

Unknown

NISND Center, Multiple Locations

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY